TELA Bio, Inc.
TELA
Price:
$2.69
Market Cap:
$66.48M
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. T...[Read more]
Industry
Medical - Devices
IPO Date
2019-11-08
Stock Exchange
NASDAQ
Ticker
TELA
The ROE as of September 2024 (TTM) for TELA Bio, Inc. (TELA) is -252.57%
According to TELA Bio, Inc.’s latest financial reports and current stock price. The company's current ROE is -252.57%. This represents a change of 73.44% compared to the average of -145.63% of the last 4 quarters.
TELA Bio, Inc. (TELA) Historical ROE (quarterly & annually)
How has TELA ROE performed in the past?
The mean historical ROE of TELA Bio, Inc. over the last ten years is -121.44%. The current -252.57% ROE has changed 107.98% with respect to the historical average. Over the past ten years (40 quarters), TELA's ROE was at its highest in in the June 2022 quarter at 865.63%. The ROE was at its lowest in in the March 2023 quarter at -447.18%.
Average
-121.44%
Median
-83.34%
Minimum
-309.94%
Maximum
19.72%
TELA Bio, Inc. (TELA) ROE by Quarter and Year
Discovering the peaks and valleys of TELA Bio, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 176.32%
Maximum Annual ROE = 19.72%
Minimum Annual Increase = -644.71%
Minimum Annual ROE = -309.94%
| Year | ROE | Change |
|---|---|---|
| 2023 | -247.15% | -20.26% |
| 2022 | -309.94% | 72.51% |
| 2021 | -179.67% | 176.32% |
| 2020 | -65.02% | -21.98% |
| 2019 | -83.34% | -644.71% |
| 2018 | 15.30% | -22.43% |
TELA Bio, Inc. (TELA) Average ROE
How has TELA ROE performed in the past?
The current ROE of TELA Bio, Inc. (TELA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-245.59%
5-year avg
-177.02%
10-year avg
-121.44%
TELA Bio, Inc. (TELA) ROE vs. Peers
How is TELA’s ROE compared to its peers?
TELA Bio, Inc.’s ROE is greater than Sight Sciences, Inc. (-45.68%), greater than Telesis Bio, Inc. (-184.13%), less than Tactile Systems Technology, Inc. (16.92%), greater than ClearPoint Neuro, Inc. (-64.23%), greater than CVRx, Inc. (-77.62%), greater than NeuroPace, Inc. (-195.26%), less than TransMedics Group, Inc. (1.96%), greater than Delcath Systems, Inc. (-379.90%), greater than RxSight, Inc. (-19.33%), greater than AxoGen, Inc. (-17.30%), greater than Treace Medical Concepts, Inc. (-49.53%), greater than Pulmonx Corporation (-50.79%), greater than Orthofix Medical Inc. (-20.68%), greater than Paragon 28, Inc. (-33.34%), greater than SI-BONE, Inc. (-24.27%), less than Varex Imaging Corporation (5.96%), greater than OrthoPediatrics Corp. (-6.73%),
| Company | ROE | Market cap |
|---|---|---|
| -45.68% | $330.02M | |
| -184.13% | $2.41M | |
| 16.92% | $330.02M | |
| -64.23% | $321.77M | |
| -77.62% | $189.32M | |
| -195.26% | $199.12M | |
| 1.96% | $5.20B | |
| -379.90% | $253.40M | |
| -19.33% | $2.15B | |
| -17.30% | $638.16M | |
| -49.53% | $340.80M | |
| -50.79% | $328.88M | |
| -20.68% | $616.14M | |
| -33.34% | $581.45M | |
| -24.27% | $653.76M | |
| 5.96% | $451.13M | |
| -6.73% | $727.88M |
Build a custom stock screener for TELA Bio, Inc. (TELA) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like TELA Bio, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
TELA Bio, Inc. (TELA) and other stocks custom spreadsheet templates
The easiest way to analyze a company like TELA Bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is TELA Bio, Inc.'s ROE?
How is the ROE calculated for TELA Bio, Inc. (TELA)?
What is the highest ROE for TELA Bio, Inc. (TELA)?
What is the 3-year average ROE for TELA Bio, Inc. (TELA)?
What is the 5-year average ROE for TELA Bio, Inc. (TELA)?
How does the current ROE for TELA Bio, Inc. (TELA) compare to its historical average?